-+ 0.00%
-+ 0.00%
-+ 0.00%

ECLIPSE LIFE SCIENCES: BETTIS‑1 TRIAL MET ITS PRIMARY ENDPOINT, DEMONSTRATING FAVORABLE SAFETY PROFILE ACROSS BOTH EC-104 FORMULATIONS

Reuters·10/15/2026 11:00:13

Please log in to view news